Home
>
US Stocks
>
ICL Israel Chemicals Ltd

ICL Israel Chemicals Ltd (ICL)

$5.5

+0.01

(+0.18%)▲

Market is closed - opens 7 PM, 02 Jun 2023

Insights on ICL Israel Chemicals Ltd

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.09B → 2.09B (in $), with an average increase of 0.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 633.0M → 280.0M (in $), with an average decrease of 31.6% per quarter

  • Vs CTVA

    In the last 1 year, ICL Group Ltd. has experienced a drawdown of -49.2%, however Corteva Inc resisted the overall trend and outperformed by 35.0%

  • Vs MOS

    In the last 3 years, Mosaic Company has given 99.4% return, outperforming this stock by 39.3%

Performance

  • $5.38
    $5.55
    $5.50
    downward going graph

    2.18%

    Downside

    Day's Volatility :3.06%

    Upside

    0.9%

    downward going graph
  • $5.43
    $10.42
    $5.50
    downward going graph

    1.27%

    Downside

    52 Weeks Volatility :47.89%

    Upside

    47.22%

    downward going graph

Returns

PeriodICL Israel Chemicals LtdSector (Materials)Index (Russel 2000)
3 Months
-23.75%
-9.0%
-6.8%
6 Months
-33.54%
-9.5%
-6.0%
1 Year
-49.17%
-11.9%
-4.6%
3 Years
60.06%
34.4%
25.9%

Highlights

Market Capitalization
7.2B
Book Value
$4.37
Dividend Share
0.784
Dividend Yield
2.07%
Earnings Per Share (EPS)
1.4
PE Ratio
3.93
PEG Ratio
9.44
Wall Street Target Price
7.48
Profit Margin
18.85%
Operating Margin TTM
32.2%
Return On Assets TTM
16.27%
Return On Equity TTM
33.1%
Revenue TTM
9.6B
Revenue Per Share TTM
7.44
Quarterly Revenue Growth YOY
-16.900000000000002%
Gross Profit TTM
5.0B
EBITDA
3.5B
Diluted Eps TTM
1.4
Quarterly Earnings Growth YOY
-0.56
EPS Estimate Current Year
0.83
EPS Estimate Next Year
0.71
EPS Estimate Current Quarter
0.21
EPS Estimate Next Quarter
0.26

Analyst Recommendation

Hold
    44%Buy
    55%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for ICL Israel Chemicals Ltd(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
4
Hold
5
5
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 36.0%

Current $5.50
Target $7.48

Company Financials

FY17Y/Y Change
Revenue
5.4B
↑ 1.03%
Net Income
364.0M
↓ 398.36%
Net Profit Margin
6.72%
↑ 8.99%
FY18Y/Y Change
Revenue
5.6B
↑ 2.55%
Net Income
1.2B
↑ 240.66%
Net Profit Margin
22.32%
↑ 15.6%
FY19Y/Y Change
Revenue
5.3B
↓ 5.13%
Net Income
475.0M
↓ 61.69%
Net Profit Margin
9.01%
↓ 13.31%
FY20Y/Y Change
Revenue
5.0B
↓ 4.33%
Net Income
11.0M
↓ 97.68%
Net Profit Margin
0.22%
↓ 8.79%
FY21Y/Y Change
Revenue
7.0B
↑ 37.91%
Net Income
783.0M
↑ 7018.18%
Net Profit Margin
11.26%
↑ 11.04%
FY22Y/Y Change
Revenue
10.0B
↑ 44.0%
Net Income
2.2B
↑ 175.73%
Net Profit Margin
21.56%
↑ 10.3%
Q4 FY21Q/Q Change
Revenue
2.0B
↑ 13.85%
Net Income
283.0M
↑ 25.78%
Net Profit Margin
13.89%
↑ 1.32%
Q1 FY22Q/Q Change
Revenue
2.5B
↑ 23.9%
Net Income
632.0M
↑ 123.32%
Net Profit Margin
25.03%
↑ 11.14%
Q2 FY22Q/Q Change
Revenue
2.9B
↑ 14.06%
Net Income
563.0M
↓ 10.92%
Net Profit Margin
19.55%
↓ 5.48%
Q3 FY22Q/Q Change
Revenue
2.5B
↓ 12.53%
Net Income
633.0M
↑ 12.43%
Net Profit Margin
25.13%
↑ 5.58%
Q4 FY22Q/Q Change
Revenue
2.1B
↓ 16.99%
Net Income
331.0M
↓ 47.71%
Net Profit Margin
15.83%
↓ 9.3%
Q1 FY23Q/Q Change
Revenue
2.1B
↑ 0.33%
Net Income
280.0M
↓ 15.41%
Net Profit Margin
13.35%
↓ 2.48%
FY17Y/Y Change
Total Assets
8.7B
↑ 1.89%
Total Liabilities
5.9B
↓ 2.06%
FY18Y/Y Change
Total Assets
8.8B
↑ 0.71%
Total Liabilities
4.9B
↓ 16.98%
FY19Y/Y Change
Total Assets
9.2B
↑ 4.52%
Total Liabilities
5.1B
↑ 5.16%
FY20Y/Y Change
Total Assets
9.7B
↑ 5.35%
Total Liabilities
5.6B
↑ 9.08%
FY21Y/Y Change
Total Assets
11.1B
↑ 14.65%
Total Liabilities
6.3B
↑ 13.77%
FY22Y/Y Change
Total Assets
11.8B
↑ 6.05%
Total Liabilities
6.0B
↓ 4.84%
Q4 FY21Q/Q Change
Total Assets
11.1B
↑ 4.81%
Total Liabilities
6.3B
↑ 4.86%
Q1 FY22Q/Q Change
Total Assets
11.7B
↑ 5.27%
Total Liabilities
6.3B
↑ 0.05%
Q2 FY22Q/Q Change
Total Assets
11.8B
↑ 0.98%
Total Liabilities
6.4B
↑ 0.55%
Q3 FY22Q/Q Change
Total Assets
11.6B
↓ 1.53%
Total Liabilities
6.1B
↓ 5.12%
Q4 FY22Q/Q Change
Total Assets
11.8B
↑ 1.31%
Total Liabilities
6.0B
↓ 0.3%
Q1 FY23Q/Q Change
Total Assets
12.0B
↑ 2.51%
Total Liabilities
6.1B
↑ 1.82%
FY17Y/Y Change
Operating Cash Flow
847.0M
↓ 12.32%
Investing Cash Flow
-333.0M
↓ 58.37%
Financing Cash Flow
-511.0M
↑ 113.81%
FY18Y/Y Change
Operating Cash Flow
620.0M
↓ 26.8%
Investing Cash Flow
331.0M
↓ 199.4%
Financing Cash Flow
-894.0M
↑ 74.95%
FY19Y/Y Change
Operating Cash Flow
992.0M
↑ 60.0%
Investing Cash Flow
-525.0M
↓ 258.61%
Financing Cash Flow
-490.0M
↓ 45.19%
FY20Y/Y Change
Operating Cash Flow
804.0M
↓ 18.95%
Investing Cash Flow
-583.0M
↑ 11.05%
Financing Cash Flow
-105.0M
↓ 78.57%
FY21Y/Y Change
Operating Cash Flow
1.1B
↑ 32.46%
Investing Cash Flow
-579.0M
↓ 0.69%
Financing Cash Flow
-244.0M
↑ 132.38%
Q4 FY21Q/Q Change
Operating Cash Flow
344.0M
↑ 26.01%
Investing Cash Flow
-22.0M
↓ 92.57%
Financing Cash Flow
-153.0M
↓ 7750.0%
Q1 FY22Q/Q Change
Operating Cash Flow
325.0M
↓ 5.52%
Investing Cash Flow
-107.0M
↑ 386.36%
Financing Cash Flow
-260.0M
↑ 69.93%
Q2 FY22Q/Q Change
Operating Cash Flow
627.0M
↑ 92.92%
Investing Cash Flow
-264.0M
↑ 146.73%
Financing Cash Flow
-351.0M
↑ 35.0%
Q3 FY22Q/Q Change
Operating Cash Flow
606.0M
↓ 3.35%
Investing Cash Flow
-176.0M
↓ 33.33%
Financing Cash Flow
-337.0M
↓ 3.99%

Technicals Summary

Sell

Neutral

Buy

ICL Israel Chemicals Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
ICL Israel Chemicals Ltd
ICL Israel Chemicals Ltd
-10.15%
-33.54%
-49.17%
60.06%
18.06%
FMC Corp.
FMC Corp.
-15.9%
-19.96%
-14.49%
5.26%
36.23%
Nutrien Ltd.
Nutrien Ltd.
-24.55%
-32.92%
-44.19%
50.27%
3.82%
Corteva, Inc.
Corteva, Inc.
-12.97%
-19.26%
-14.18%
99.44%
84.45%
CF Industries Holdings, Inc.
CF Industries Holdings, Inc.
-14.51%
-40.65%
-35.6%
107.87%
51.99%
Mosaic Company, The
Mosaic Company, The
-26.68%
-34.91%
-45.54%
155.27%
15.55%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
ICL Israel Chemicals Ltd
ICL Israel Chemicals Ltd
3.93
3.93
9.44
0.83
0.33
0.16
0.02
4.37
FMC Corp.
FMC Corp.
16.13
16.13
1.85
7.74
0.25
0.07
0.02
27.76
Nutrien Ltd.
Nutrien Ltd.
4.24
4.24
NA
6.8
0.28
0.1
0.04
50.92
Corteva, Inc.
Corteva, Inc.
32.34
32.34
1.31
2.97
0.05
0.03
0.01
36.02
CF Industries Holdings, Inc.
CF Industries Holdings, Inc.
4.13
4.13
0.64
9.23
0.48
0.22
0.03
27.98
Mosaic Company, The
Mosaic Company, The
4.09
4.09
0.2
5.3
0.24
0.11
0.02
35.81
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
ICL Israel Chemicals Ltd
ICL Israel Chemicals Ltd
Hold
$7.2B
18.06%
3.93
18.85%
FMC Corp.
FMC Corp.
Buy
$13.0B
36.23%
16.13
12.51%
Nutrien Ltd.
Nutrien Ltd.
Buy
$27.0B
3.82%
4.24
19.32%
Corteva, Inc.
Corteva, Inc.
Buy
$39.2B
84.45%
32.34
6.64%
CF Industries Holdings, Inc.
CF Industries Holdings, Inc.
Buy
$12.1B
51.99%
4.13
29.26%
Mosaic Company, The
Mosaic Company, The
Hold
$11.1B
15.55%
4.09
15.08%

Institutional Holdings

  • Goldman Sachs Group Inc

    0.15%

  • Achmea Investment Management B.V.

    0.02%

  • SIMPLEX TRADING, LLC

    0.01%

  • Ativo Capital Management LLC

    0.01%

Corporate Announcements

  • ICL Israel Chemicals Ltd Dividends September,2023

    In the quarter ending September,2023. ICL Israel Chemicals Ltd has declared dividend of $0.11

    Read More

Company Information

ICL Group Ltd. is a multi-national manufacturing concern that develops, produces and markets fertilizers, metals and other special-purpose chemical products. ICL serves primarily three markets: agriculture, food and engineered materials.

Organization
ICL Israel Chemicals Ltd
Employees
12500
CEO
Mr. Raviv Zoller
Industry
Process Industries

Discover More

FAQs